Antiseizure medication at discharge in infants with hypoxic-ischaemic encephalopathy: an observational study.
Elizabeth K SewellSeetha ShankaranScott A McDonaldShannon E G HamrickCourtney J WusthoffIra Adams-ChapmanLina F ChalakAlexis S DavisKrisa Van MeursAbhik DasNathalie MaitreAbbott LaptookRavi Mangal Patelnull nullPublished in: Archives of disease in childhood. Fetal and neonatal edition (2023)
In infants with HIE and seizures, continuation of ASM at discharge varies substantially among centres and may be associated with a higher risk of death or disability at 18-22 months of age.